Bio-Techne TECH Impairment Charges
Discontinued — last reported Q4 '25
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf.
The official record: Bio-Techne’s 10-K, filed August 22, 2025, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's impairment charges?
- Bio-Techne (TECH) reported impairment charges of $84.16M in Q2 2025.
- How has Bio-Techne's impairment charges changed year-over-year?
- Bio-Techne's impairment charges increased by 428.5% year-over-year, from $15.93M to $84.16M.
- What does impairment charges mean?
- Non-cash accounting write-downs of asset values due to impairment.
- How do you interpret impairment charges?
- An increase signals potential operational challenges or overvaluation of past acquisitions, suggesting future earnings pressure.
- How does impairment charges compare across companies?
- Common in capital-intensive industries or companies with high M&A activity; peers often report these during restructuring cycles.